ps://www.biospace.com/article/releases/gc-biopharma-announces-us-fda-approval-for-alyglo-immune-globulin-intravenous-human-stwk-10-percent-liquid-for-adults-with-primary-humoral-immunodeficiency-pi-/
请参阅随附的FILSUVEZ完整处方信息：https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fb97b3ec-29ee-4df1-aa99-c23e57a21228
|
